Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lyell Immunopharma (LYEL) Shares Outstanding: 2019-2021

Historic Shares Outstanding for Lyell Immunopharma (LYEL) over the last 3 years, with Dec 2021 value amounting to $242.7 million.

  • Lyell Immunopharma's Shares Outstanding rose 1459.01% to $242.7 million in Q4 2021 from the same period last year, while for Dec 2021 it was $242.7 million, marking a year-over-year increase of 1459.01%. This contributed to the annual value of $242.7 million for FY2021, which is 1459.01% up from last year.
  • Per Lyell Immunopharma's latest filing, its Shares Outstanding stood at $242.7 million for FY2021, which was up 1,459.01% from $15.6 million recorded in FY2020.
  • In the past 5 years, Lyell Immunopharma's Shares Outstanding registered a high of $242.7 million during FY2021, and its lowest value of $11.2 million during FY2019.
  • Over the past 3 years, Lyell Immunopharma's median Shares Outstanding value was $15.6 million (recorded in 2020), while the average stood at $89.8 million.
  • Data for Lyell Immunopharma's Shares Outstanding shows a peak YoY skyrocketed of 1,459.01% (in 2021) over the last 5 years.
  • Over the past 3 years, Lyell Immunopharma's Shares Outstanding (Yearly) stood at $11.2 million in 2019, then surged by 39.25% to $15.6 million in 2020, then soared by 1,459.01% to $242.7 million in 2021.